ABSTRACT
Thalassemia intermedia encompasses clinical conditions ranging in severity from, thalassemia carrier sate to transfusion dependent major like. Therefore, classification of patients in useful for proper counseling, management and prenatal diagnosis. We followed a special scoring system for classification of 155 beta-thalassemia intermedia patients. According to this system the patients were classified into mild [23.2%], moderate [27.7%] and severe [49.1%]. Molecular studies for detection of mutations were done for 66 of the cases using Reverse Dot Blot [RDB] and Amplification Refractory Mutation System [ARMS] techniques. Genotypes were compared with the clinical classifications. The mild beta[++]/beta[++] genotype was detected in 38.8% of the mild, 45% of the moderate and 21% of the severe group. We concluded that, the clinical scoring of severity of thalassemia intermedia is useful to develop management guidelines for the subgroups and that severity could not be always explained by the underlying genotype. Search for other mechanisms or modifying factors is needed for proper prognosis, genetic counseling and future